BRCA1 and meningioma: CREBBP, PIK3CA (R108H), PIK3R1, BRCA1, and SMARCB1 are the most represented mutations; unfortunately, none of these mutations can predict the rate of recurrence in NF2-mutated meningiomas [20,22].